Fig. 1

Trends in hemoglobin levels: estimated marginal means of hemoglobin (Hb) levels over the six-month follow-up period in Sudanese children with end-stage kidney disease (ESKD) undergoing treatment with erythropoietin-stimulating agents (ESAs)